Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
NHS England’s Medical Director has challenged patients, NHS staff, industry leaders and politicians to radically change the way they deal with healthcare services.
Making the first key speech of the NHS Health and Care Innovation Expo, Professor Sir Bruce Keogh said everyone involved in the NHS had to play their part in making sure the service can deal with the “quadruple pincer” of difficult increasing demand, escalating costs, a tightened fiscal environment and increasing patient expectations.
Looking back to the establishment of the NHS in the aftermath of the Second World War, Sir Bruce said the current difficult times, if handled in the right way, could herald a new era of innovation and development. He reminded representatives from right across the health and social care sector of England’s unique environment supporting science and innovation, fostering more than twice as many Nobel prizes for Medicine and Physiology per capita in this country than anywhere else in the world.
Sir Bruce said: “To patients, I say be more confident and more assertive – do your research, don’t be shy to ask questions and, crucially, don’t be shy to take charge.
“To front-line clinical and managerial staff, I say please, do not aspire to mediocrity. I hear people talk about meeting the European average. I have no interest in meeting the European average and I hope you don’t either. We need to always aspire to excellence and must not be constrained to the normal, the usual, the middle of the pack.
“Push the boundaries. Do not ignore cost, but seek value because it is through value that we will acquire the best possible treatment for everyone. Show courage, and give each other permission to try new things. Take risks with processes, but not with clinical outcomes. And through all of this, help turn taxpayers’ money into good clinical outcomes.
Sir Bruce called on industry leaders to do business in the UK, hailing low corporation tax that reduces further for profits earned on UK international patents and gives significant tax rebate for research expenditure as “remarkable incentive” for innovation.
He challenged politicians to develop policies that “unleash rather than constrain” the intellectual capital of the NHS’s 1.4 million staff.